CD274 and cancer: Alterations of mitochondria, both in the cancer and the immune cells of the TME, leads to an immunosuppressive condition (Figure 1) and limited sensitivity to immunotherapies by overexpressing PD-1 and PD-L1 signaling pathways (104).